Program in Clinical Research, Clinical Support Services and Clinical Training
Program in Clinical Research, Clinical Support Services and Clinical Training
批准号:
8929844
负责人:
Frederick Miller
金额:
$597.95万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAreaAsthmaAutoimmunityBackCardiovascular DiseasesCellsCentrifugationClient satisfactionClinicalClinical ProtocolsClinical ResearchClinical ServicesClinical Trials DatabaseCollaborationsCore FacilityDNADNA DamageDevelopmentDiseaseDrug KineticsEducationEducational workshopElectronic Health RecordElectronicsEndocrineEngineeringEnrollmentEnsureEnvironmental ExposureEpitheliumEthicsGenerationsGenetic PolymorphismGoalsGuidelinesHealthHumanHuman RightsHuman Subject ResearchImmuneImmunologyIndividualInflammationInflammatoryInstitutesInstitutionInstitutional Review BoardsInvestigationLungLung diseasesMalignant NeoplasmsMetabolic DiseasesMissionMonitorNational Institute of Environmental Health SciencesNorth CarolinaNursing ResearchParticipantPatient RecruitmentsPatientsPhenotypePopulationProceduresProcessProtocols documentationRegistriesRegulationResearchResearch DesignResearch PersonnelResearch Project GrantsRespiratory SystemRespiratory tract structureRightsSamplingScientistSeriesServicesSocial WelfareSpecimenStructureSusceptibility GeneSystemTestingTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkceric oxideclinical research sitecohortdrug testingfollow-upinjury and repairmulti walled carbon nanotubenanonanomaterialsnanoparticleoperationprogramsprotocol developmentquality assurancereceptorsymposiumtranslational studyweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The NIEHS Clinical Research Program Team has continued to expand its scope of support for clinical and translational studies. The NIEHS Clinical Research Unit (CRU) has recorded over 5000 patient encounters with over 95% patient satisfaction. Additional staff have been hired to support CRU functions. The NIEH's CRU is integrated into the Bethesda CC via the CRIS electronic health record system and the Clinical Trials Database, and collaborated with the NIEHS Environmental Autoimmunity Group in Bethesda. Studies are currently underway at the CRU, involving the fields of asthma, cancer, cardiovascular disease, immunology, inflammation, metabolic disease, and pharmacokinetics. Many studies take advantage of the Environmental Polymorphisms Registry (EPR), a NIEHS-operated cohort encompassing over 15,000 North Carolina residents, who have donated DNA and have agreed to be called back for phenotypic studies. EPR-related follow-up studies address issues of inflammation, DNA injury repair, endocrine receptor polymorphisms, endothelial function and lung disease. Furthermore, collaboration avenues with local universities as well as other governmental agencies are currently underway. Finally, the NIEHS CRU is leading a Nano-Health initiative, investigating the effect of engineered nanomaterials on human health, with special emphasis on susceptible populations, such as subjects with pre-existing disease. We are currently investigating the toxic and pro-inflammatory effects of cerium dioxide nanoparticles and multi-walled carbon nanotubes on circulating and resident lung immune cells, as well as epithelia along the respiratory tract. The NIEHS Program in Clinical Research has established a comprehensive Human Research Protection Program thru the development of the Office of Human Research Compliance (OHRC). This office is responsible for managing and coordinating the pre-IRB clinical and scientific review of NIEHS clinical studies, supporting the day to day administrative operations of the IRB, Developing and maintaining electronic management systems and websites that support activities of the OHRC, Performing quality assurance/quality improvement audits of clinical sites, strengthening and enhancing the human research protection education and training program, working with scientific / clinical PIs and their staff to develop human research protocols, developing and implementing standard operational procedures, to ensure that NIEHS complies with DHHS, FDA, NIH guidelines and regulations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:10012666
-
项目类别:
-
资助金额:$108.32万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:8929773
-
项目类别:
-
资助金额:$181.13万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:8336614
-
项目类别:
-
资助金额:$193.18万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:7734522
-
项目类别:
-
资助金额:$128.85万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:10012665
-
项目类别:
-
资助金额:$210.94万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Program in Clinical Research, Clinical Support Services and Clinical Training
-
批准号:8554185
-
项目类别:
-
资助金额:$464.7万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:9550108
-
项目类别:
-
资助金额:$189.12万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:10252585
-
项目类别:
-
资助金额:$249.74万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:8336615
-
项目类别:
-
资助金额:$78.79万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:9143472
-
项目类别:
-
资助金额:$212.9万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:9352125
-
项目类别:
-
资助金额:$175.38万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:7968168
-
项目类别:
-
资助金额:$87.09万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:8553763
-
项目类别:
-
资助金额:$167.09万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:7734521
-
项目类别:
-
资助金额:$136.9万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:8149079
-
项目类别:
-
资助金额:$72.32万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:8734132
-
项目类别:
-
资助金额:$80.57万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:8734131
-
项目类别:
-
资助金额:$172.92万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:8553764
-
项目类别:
-
资助金额:$75.38万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Assessment, Therapy and Prevention Of Autoimmune Disease
-
批准号:10252586
-
项目类别:
-
资助金额:$106.86万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
-
批准号:8149078
-
项目类别:
-
资助金额:$144.64万
-
财政年份:--
-
负责人:Frederick Miller
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: